Citations

Showing 10 of 108083 citations.

Clinical Phenotypes of Dual Kidney Transplant Recipients in the United States as Identified through Machine Learning Consensus Clustering
Tangpanithandee, Supawit , Jadlowiec, Caroline C. , Mao, Shennen A. , Mao, Michael A. , Vaitla, Pradeep , Leeaphorn, Napat , Kaewput, Wisit , Pattharanitima, Pattharawin , Krisanapan, Pajaree , Nissaisorakarn, Pitchaphon , Cooper, Matthew , Cheungpasitporn, Wisit , Jadlowiec, Caroline , Mao, Shennen A , Mao, Michael A , Kaewput, Wisit , Pattharanitima, Pattharawin , Krisanapan, Pajaree , Nissaisorakarn, Pitchaphon , Cheungpasitporn, Wisit , Cooper, Matthew , Tangpanithandee, Supawit , Thongprayoon, Charat

Mayo Clinic

Medicina | December 13, 2022 | Volume: 58 | Issue: 12 | Pages: 1831

10.3390/medicina58121831 | PMID 36557033 Get It

Background and Objectives: Our study aimed to cluster dual kidney transplant recipients using an unsupervised machine learning approach to characterize donors and recipients better and to compare the survival outcomes across these various clusters. Materials and Methods: We performed consensus cluster analysis based on recipient-, donor-, and transplant-related characteristics in 2821 dual kidney transplant recipients from 2010 to 2019 in the OPTN/UNOS database. We determined the important characteristics of each assigned cluster and compared the post-transplant outcomes between clusters. Results: Two clinically distinct clusters were identified by consensus cluster analysis. Cluster 1 patients was characterized by younger patients (mean recipient age 49 ± 13 years) who received dual kidney transplant from pediatric (mean donor age 3 ± 8 years) non-expanded criteria deceased donor (100% non-ECD). In contrast, Cluster 2 patients were characterized by older patients (mean recipient age 63 ± 9 years) who received dual kidney transplant from adult (mean donor age 59 ± 11 years) donor with high kidney donor profile index (KDPI) score (59% had KDPI ≥ 85). Cluster 1 had higher patient survival (98.0% vs. 94.6% at 1 year, and 92.1% vs. 76.3% at 5 years), and lower acute rejection (4.2% vs. 6.1% within 1 year), when compared to cluster 2. Death-censored graft survival was comparable between two groups (93.5% vs. 94.9% at 1 year, and 89.2% vs. 84.8% at 5 years). Conclusions: In summary, DKT in the United States remains uncommon. Two clusters, based on specific recipient and donor characteristics, were identified through an unsupervised machine learning approach. Despite varying differences in donor and recipient age between the two clusters, death-censored graft survival was excellent and comparable. Broader utilization of DKT from high KDPI kidneys and pediatric en bloc kidneys should be encouraged to better address the ongoing organ shortage.
B cell acute lymphoblastic leukemia (B-ALL) associated with hypereosinophilia: A case report and review of the literature
Barary, Mohammad , Pirzaman, Ali Tavakoli , Mousavi‐Fatemi, Khatereh, Sio, Terence T., Barary, Mohammad , Tavakoli Pirzaman, Ali

Mayo Clinic

No container title available | December 13, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.167091131.14409365/v1 Get It

Few cases of eosinophilia associated with B cell acute lymphoblastic leukemia (B-ALL) have been reported. This study reported a 16-year-old male patient diagnosed with B-ALL and hypereosinophilia. He was admitted to the emergency department (ED) with urticaria and generalized itching. On initial examination, the skin was wholly erythematous, and urticarial lesions were scattered throughout the body. Peripheral blood smear (PBS) was examined, and eosinophils were seen in different fields. However, blast cells were not seen in the PBS. In bone marrow examination, terminal deoxynucleotidyl transferase (TdT)-positive and CD20-positive lymphoid blasts were reported along with eosinophilia. In immunohistochemical (IHC) staining, results were within normal limits for the fibroblast growth factor receptor 1 (FGFR1), platelet-derived growth factor receptor alpha (PDGFRα), and platelet-derived growth factor receptor beta (PDGFRβ) genes expressions. Moreover, no breakpoint cluster region (BCR)/Abelson murine leukemia 1 (ABL1) mRNA transcripts and no Janus kinase 2 (JAK2) V617F mutation were detected. Eventually, the B-ALL diagnosis was confirmed for the patient, and he was started on the Berlin-Frankfurt-Münster (BFM) chemotherapy regimen. The patient was transferred to another facility and is continuing his treatment there.
Opportunities for Antimicrobial Stewardship in Caring for Febrile Pediatric Inpatients in Abu Dhabi
Abass, Maha Khalil , Nsutebu, Emmanuel , Fischer, Philip R. , Khan, Junaid Ali

Mayo Clinic

Global Pediatric Health | December 13, 2022 | Volume: 9 | Issue: No issue available | Pages: No page available

10.1177/2333794x221127639 | PMID 36531930 Get It

Antimicrobial stewardship programs seek to improve patient outcomes, reduce cost, and hinder development of antimicrobial resistance. Collection of inpatient antimicrobial use data is foundational to these programs, and decisions to initiate and discontinue antibiotics are potentially amenable to improvement. In order to better understand our current practices and with a view toward improved antimicrobial stewardship, we reviewed charts of previously healthy children to age 16 years hospitalized with fever (without an evident localized source) and/or other findings suggestive of serious bacterial infection. Of 105 patients (18% 0-2 months of age, 42% 3-12 months, 25% 2-5 years), 100 (95%) received antibiotics, 72% for more than 2 days. Of 98 patients with negative body fluid cultures, 23 received antibiotics for 2 days or less, and 70 received antimicrobial therapy for more than 2 days. Focusing on selective initiation and earlier discontinuation of antimicrobial therapy in hospitalized children might reduce unnecessary antibiotic use.
Intraoperative Ergonomic Assessment of Exoscopes versus Conventional DIEP Flap
Wang, Tianke , Nguyen, Minh-Doan T. , Harless, Christin A., Smith, Tianqi Gao, Norasi, Hamid , Nguyen, Minh-Doan, Harless, Christin, Smith, Tianqi G, Hallbeck, Susan, Law, Katherine E. , Tetteh, Emmanuel , Hallbeck, M. Susan

Mayo Clinic

Journal of Reconstructive Microsurgery | December 13, 2022 | Volume: 39 | Issue: 06 | Pages: 453-461

10.1055/s-0042-1758188 | PMID 36509101 Get It

Abstract Background This study compared the ergonomics of surgeons during deep inferior epigastric perforator (DIEP) flap surgery using either baseline equipment (loupes, headlights, and an operating microscope) or an exoscope. Plastic surgeons may be at high risk of musculoskeletal problems. Recent studies indicate that adopting an exoscope may significantly improve surgeon postures and ergonomics. Methods Postural exposures, using inertial measurement units at the neck, torso, and shoulders, were calculated in addition to the surgeons' subjective physical and cognitive workload. An ergonomic risk score on a scale of 1 (lowest) to 4 (highest) was calculated for each of the postures observed. Data from 23 bilateral DIEP flap surgeries (10 baseline and 13 exoscope) were collected. Results The neck and torso risk scores decreased significantly during abdominal flap harvest and chest dissection, while right shoulder risk scores increased during the abdominal flap harvest for exoscope DIEP flap procedures compared with. Exoscope anastomoses demonstrated higher neck, right shoulder, and left shoulder risk scores. The results from the survey for the “surgeon at abdomen” showed that the usage of exoscopes was associated with decreased performance and increased mental demand, temporal demand, and effort. However, the results from the “surgeon at chest” showed that the usage of exoscopes was associated with lower physical demand and fatigue, potentially due to differences in surgeon preference. Conclusion Our study revealed some objective evidence for the ergonomic benefits of exoscope; however, this is dependent on the tasks the surgeon is performing. Additionally, personal preferences may be an important factor to be considered in the ergonomic evaluation of the exoscope.
Monoclonal Gammopathy of Undetermined Significance
Rajkumar, S. Vincent , Rajkumar, S Vincent , Gonsalves, Wilson I.

Mayo Clinic

Annals of Internal Medicine | December 12, 2022 | Volume: 175 | Issue: 12 | Pages: ITC177-ITC192

10.7326/aitc202212200 | PMID 36508741 Get It

Classifying the Large Vestibular Aqueduct: Morphometry to Audiometry
Deep, Nicholas L. , Carlson, Matthew L. , Driscoll, Colin L. W., Lohse, Christine M. , Lane, John I. , Ho, Mai‐Lan , Ho, Mai-Lan , Hoxworth, Joseph M.

Mayo Clinic

Otology & Neurotology | December 12, 2022 | Volume: 44 | Issue: 1 | Pages: 47-53

10.1097/mao.0000000000003748 | PMID 36509439 Get It

Objective Large vestibular aqueduct (LVA) is the most common inner ear dysplasia identified in patients with hearing loss. Our objective was to systematically quantify LVA morphologies and correlate imaging findings with established audiometric outcomes. Study Design Retrospective review. Setting Tertiary referral center. Patients Patients with large vestibular aqueduct identified radiographically, with or without hearing loss. Intervention(s) Diagnostic only. Main Outcome Measure(s) Vestibular aqueduct (VA) width at midpoint, width at external aperture, and length were measured on cross-sectional imaging. Morphology was classified as type I (borderline), type II (tubular), or type III (funneled). Audiometric endpoints included air/bone conduction, pure tone averages, and air-bone gaps at 250 and 500 Hz. Statistical associations were evaluated using linear regression models, adjusted for age at first audiogram and sex. Results One hundred seventeen patients (197 ears) were included, with mean age at first audiogram of 22.2 years (standard deviation, 21.7 yr). Imaging features associated with poor audiometric outcomes were increasing VA width at midpoint and external aperture, decreasing VA length, dilated extraosseous endolymphatic sac, cochleovestibular malformations, and increasing VA type (III > II > I). Conclusions Quantitative LVA measurements and a standardized morphologic classification system aid in prediction of early audiometric endpoints.
Experience with Telemedicine in a Tertiary Academic Otologic Clinic During the COVID-19 Pandemic
Xie, Katherine , Gottlich, Harrison C., Yeakel, Sarah, Nassiri, Ashley M. , Moore, Eric J. , Carlson, Matthew L. , Xie, Katherine Z , Antezana, Luis A.

Mayo Clinic

Otology & Neurotology | December 12, 2022 | Volume: 44 | Issue: 1 | Pages: 72-80

10.1097/mao.0000000000003755 | PMID 36509445 Get It

Objective To examine the utility of telemedicine in a tertiary otologic practice. Study Design Retrospective case series. Setting Tertiary neurotology clinic. Patients Consecutive adult patients presenting via video visit between January 2020 and January 2021. Intervention(s) Televideo modality to conduct visits with patients seeking evaluation for new concerns, second opinions, or routine follow-up for established conditions. Main Outcome Measure(s) Success of the televideo visit defined by the televideo visit being sufficient for determining a definitive plan and not requiring deferment of recommendations for a subsequent in-person visit. Results A total of 102 televideo visits were performed among 100 unique patients. Of those, 92 (90.2%) visits were for second opinions or evaluation of new concerns, most commonly for vestibular schwannoma (n = 32, 31.4%), followed by sensorineural hearing loss (n = 20, 19.6%). Other visits were conducted for early postoperative follow-up and established general follow-up. In 91.2% of cases (n = 93), patients were successfully evaluated and provided recommendations from the initial video visit. All visits with patients having a diagnosis of meningioma (n = 7), and nearly all with vestibular Schwannoma (97%, n = 31) and sensorineural hearing loss (95%, n = 19) were successful. Of the 79 patients offered surgery as one potential treatment option, 31 patients underwent surgery at our institution by time of review. Patients with unsuccessful visits (n = 9, 8.8%) were advised to schedule additional in-person diagnostic imaging, vestibular testing, or cochlear implant candidacy evaluation to establish a more definitive care plan. Conclusion Virtual televideo visits were successful for a high percentage of selected patients seen at a tertiary neurotology practice, particularly those seeking evaluation of vestibular schwannoma or sensorineural hearing loss.
Periodic limb movements in sleep and neuroimaging findings
Dredla, Brynn K., Brutto, Óscar H. Del , Castillo, Pablo R. , Del Brutto, Oscar H , Castillo, Pablo R

Mayo Clinic

Sleep | December 12, 2022 | Volume: 46 | Issue: 2 | Pages: No page available

10.1093/sleep/zsac303 | PMID 36507891 Get It

Disseminated Group G Streptococcus mimicking systemic vasculitis with skin, lung, and eye manifestations:  A Case Report.
Bartels, Helen Caroline , Pham, Michael M

Mayo Clinic

No container title available | December 12, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2163739/v1 Get It

Abstract Background: Group G streptococcal species can represent normal human flora as asymptomatic colonization. In the setting of infection, group G streptococcus can invade multiple structures and present broadly including bacteremia, toxic shock syndrome, endocarditis, septic arthritis, osteomyelitis, necrotizing skin infections, pharyngitis, and others. Severe cases tend to be more common in patients of increasing age or with chronic illnesses. Here we report a case of disseminated group G streptococcus mimicking systemic vasculitis. Case Presentation: A 41-year-old white male was hospitalized with a five-day history of fevers, chills, painful bilateral leg rash, generalized arthralgias, and right eye redness, pain and severe vision loss. Medical history was significant for minimal change disease treated with prednisone and cyclosporine. On admission, he was noted to be cushingoid with edematous erythema at the left hand, and bilateral lower limb rash. The right eye was inflamed with hypopyon. Laboratory studies demonstrated mild leukocytosis, modest thrombocytopenia, hyponatremia, hyperglycemia, with elevated CRP and creatinine. Urinalysis was positive for proteinuria, microscopic hematuria, and pyuria. CT chest demonstrated right upper lobe consolidation. There was concern for systemic vasculitis and cellulitis of the left hand. Intravenous methylprednisolone and empiric antibiotics were initiated. Ophthalmology was consulted for right uveitis and aspirated fluid from the anterior chamber. Dermatology biopsied the lower limb rash and identified leukocytoclastic vasculitis. Pulmonology performed bronchoscopy and bronchoalveolar lavage of the right upper lobe. Prior renal pathology was re-reviewed. Rheumatology was consulted due to suspicions for systemic vasculitis. Lancefield group G streptococcus was ultimately cultured from multiple blood samples, bronchoalveolar lavage fluid and right eye aspirate. There was no evidence of endocarditis on imaging. It was concluded that the source of the bacteremia and disseminated infection was most likely the left-hand cellulitis. Conclusions: To our knowledge, we present the first case of disseminated Group G streptococcal infection presenting with the constellation of bacteremia, endophthalmitis, focal mass-like lung consolidation, and leukocytoclastic vasculitis of lower extremities. The multi-organ distribution mimicked a systemic small vessel vasculitis. This case highlights the importance of infectious etiologies in the differential diagnosis of vasculitis – especially in the setting of infectious risk factors.
Osteoarthritis gene therapy in 2022
Evans, Christopher H. , Ghivizzani, Steven C. , Robbins, Paul D.

Mayo Clinic

Current Opinion in Rheumatology | December 12, 2022 | Volume: 35 | Issue: 1 | Pages: 37-43

10.1097/bor.0000000000000918 | PMID 36508307 Get It

Purpose of review To assess the present status of gene therapy for osteoarthritis (OA). Recent findings An expanding list of cDNAs show therapeutic activity when introduced into the joints of animals with experimental models of OA. In vivo delivery with adenovirus or adeno-associated virus is most commonly used for this purpose. The list of encoded products includes cytokines, cytokine antagonists, enzymes, enzyme inhibitors, growth factors and noncoding RNA. Elements of CRISPR-Cas have also been delivered to mouse knees to ablate key genes. Several human trials have been initiated, using transgenes encoding transforming growth factor-β 1 , interleukin-1 receptor antagonist, interferon-β, the NKX3.2 transcription factor or variant interleukin-10. The first of these, using ex vivo delivery with allogeneic chondrocytes, gained approval in Korea which was subsequently retracted. However, it is undergoing Phase III clinical trials in the United States. The other trials are in Phase I or II. No gene therapy for OA has current marketing approval in any jurisdiction. Summary Extensive preclinical data support the use of intra-articular gene therapy for treating OA. Translation is beginning to accelerate and six gene therapeutics are in clinical trials. Importantly, venture capital has begun to flow and at least seven companies are developing products. Significant progress in the future can be expected.